Euticals is a chemical company established in 1984 and is focused on active pharmaceutical ingredients, regulatory starting materials, high-tech building blocks and cGMP intermediates.
Based in Milano, Italy, Euticals has operations in Italy, the United States, France and Germany. The yearly revenue is approx. 250 Mio EUR (2012).
A broad portfolio of Antineoplastics, Cardiovasculars, CNS, Immunosuppressants, Neuromuscular blocking agents, Phospholipids and Nootropics, Antibiotics among others.
Providing large volume intermediates manufacturing capacity at competitive prices.
Broad technological expertise with offerings from boronic acids to prostaglandin precursors, organo\metalic, cross coupling and enzymatic chemistry. Offering of high performance reagents like T3P and special Iodine compounds.

Euticals GmbH is a subsidiary of AMRI